Trump’s Push to Lower Drug Prices Amidst Controversy and Financial Concerns
A Mounjaro KwikPen, containing Tirzepatide, represents the type of weight-loss drug targeted by former President Trump’s agreements with pharmaceutical companies to lower costs. This initiative aims to improve access and address obesity among beneficiaries.| Image Source: Wikimedia Commons In an ambitious move to lower healthcare costs and address the escalating obesity crisis, former President Donald Trump…